Nana Hawa Yayah Jones
Pediatric Endocrinology · Cincinnati, OHNPI 1154596518
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $74,364 of the $91,857 with a category attached, or 81.0%. Medtronic accounts for 86.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $33,959 and has fallen 86.5% since, to $4,598 in 2025. Among pediatric endocrinology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $540.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$80K
- Companion Medical, Inc.$3K
- Sanofi-aventis U.S. LLC$3K
- IBSA Institut Biochimique SA$2K
- Tandem Diabetes Care, Inc.$863
- Ascendis Pharma Endocrinology Inc$655
- plus $2K from 10 others
Across 2 payments — averaging $4368.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- IBSA Institut Biochimique SA$9K
What the payments were for
- Consulting fees$2,1702%
- Speaking & faculty fees$74,36481%
- Travel & lodging$9,01410%
- Food & beverage$6,3097%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 128 | $79,844 |
| Companion Medical, Inc. | 2 | $3,000 |
| Sanofi-aventis U.S. LLC | 7 | $2,835 |
| IBSA Institut Biochimique SA | 3 | $2,377 |
| Tandem Diabetes Care, Inc. | 4 | $863 |
| Ascendis Pharma Endocrinology Inc | 5 | $655 |
| Dexcom, Inc. | 6 | $519 |
| Novo Nordisk | 4 | $487 |
| Insulet Corporation | 4 | $441 |
| BETA Bionics, Inc. | 1 | $149 |
| Endo USA, Inc. | 1 | $139 |
| Eton Pharmaceuticals, Inc. | 1 | $126 |
| Gynesonics, Inc. | 1 | $124 |
| Mannkind Corporation | 1 | $118 |
| Sequel Med Tech, LLC | 1 | $112 |
| Biomarin Pharmaceutical Inc. | 1 | $69 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INPEN SMART INSULIN DELIVERY SYSTEM$35,837
- InPen$32,176
- MINIMED 770G$3,108
- TZIELD$2,818
- Tirosint$2,377
- MINIMED 780G$1,996
- iPro2$1,240
- t-slim insulin pump$771
- SKYTROFA$559
- iLet Bionic Pancreas$446
- Omnipod$344
- DEXCOM G7 GSS (161)$160
- SUPPRELIN$139
- DEXCOM G6 TRANSMITTER$136
- Alkindi$126
- KHINDIVI$126
- INCRELEX$126
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$124
- AFREZZA$118
- TWIIST$112
How this compares
$91,857 in reported general payments places this provider in the 95th percentile of 76 pediatric endocrinology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HumalogInsulin Lispro | 11 | $1,391 |
| Testosterone Cypionate | 12 | $644 |
Paid to pharmacies, not to this prescriber.
Other pediatric endocrinology in Cincinnati
- Philippe BackeljauwCincinnati$632K
- Andrew DauberCincinnati$192K
- Susan RoseCincinnati$17K
- Iris Gutmark-LittleCincinnati$14K
- Halley WassermanCincinnati$9K
- Amy ShahCincinnati$8K
- Ryan BradyCincinnati$5K
- Nicole SheanonCincinnati$3K
- Deborah ElderCincinnati$2K
- David KleinCincinnati$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.